Transthyretin expression in the postischemic brain.

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Transthyretin (TTR) is a carrier protein with an uncharacterized role in post-stroke functional recovery.
• Investigating TTR expression in the ischemic brain is crucial for understanding stroke pathophysiology.

Purpose of the Study:

• To investigate the expression and localization of transthyretin (TTR) in the brain following experimental ischemic stroke.
• To determine if TTR synthesized within the brain contributes to tissue reorganization in the early post-stroke period.

Main Methods:

• Permanent focal ischemia induced by photothrombosis (PT) in male C57/B6 mice.
• Analysis of ttr gene expression and TTR protein levels using RT-PCR, Western blot, and immunohistochemistry at 24 hours, 48 hours, 7 days, and 14 days post-PT.
• Immunohistochemistry utilized cell-specific markers (NeuN, GFAP, CD68) to identify cell types.

Main Results:

• No TTR immunoreactivity was detected in neurons, astrocytes, or microglia within the ischemic core or peri-infarct region.
• TTR protein was not detected by immunoblotting in brain tissue extracts from the ischemic territory.
• RT-PCR analysis did not reveal ttr expression in the ischemic brain at any time point.
• TTR-like immunoreactive globules, not attributable to specific brain cells, were observed in the ischemic core and peri-infarct area 14 days post-PT.

Conclusions:

• Transthyretin (TTR) is not synthesized by resident brain cells in the ischemic infarct core and adjacent areas within 14 days of photothrombotic stroke.
• The findings suggest that TTR synthesized in situ within the brain is unlikely to play a role in tissue reorganization during the early phase of recovery after experimental stroke.